Fuat Kızılay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fuat Kızılay has a total of 245 co-authors. Here are the top co-authors by number of shared publications:
- Adnan Şimşir
Department of Urology, Faculty of Medicine, Ege University, Izmir, Turkey
23 shared publications - Serdar Kalemci
Department of Urology, Faculty of Medicine, Ege University, Izmir, Turkey
21 shared publications - Baris Altay
Department of Urology, Faculty of Medicine, Ege University, İzmir 35100, Türkiye
10 shared publications - Kasim Emre Ergun
Department of Urology, Faculty of Medicine, Ege University, Izmir, Turkey
9 shared publications - Banu Sarsik Kumbaraci
Department of Pathology, Ege University School of Medicine, Izmir, Türkiye
7 shared publications Adnan Şimşir
Dr. Adnan Simsir, Department of Urology, Ege University School of Medicine, Izmir, Turkey
6 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5163
Upper Urinary System Changes After Radical Cystectomy and Bricker Urinary Diversion: A Retrospective Evaluation of Functional and Radiological Parameters
Background/Objectives: Our objective is to evaluate the long-term effects of radical cystectomy and Bricker ileal conduit urinary diversion on upper urinary tract function and structure, with a specific focus on radiological and laboratory changes in renal function. Methods: A retrospective analysis was conducted of 120 patients who underwent radical cystectomy (RC) and Bricker ileal conduit urinary diversion between 2010 and 2024. Clinical, laboratory, and radiological data were assessed over a 24-month follow-up period. Renal parenchymal thickness, kidney volumes, and hydronephrosis grades were analyzed, and the relationship between interventions and renal outcomes was examined. Results: Postoperative follow-up showed a progressive decrease in renal parenchymal thickness and kidney volume, particularly in the left kidney. Hydronephrosis occurred in both renal units, with higher rates on the left side. Despite these changes, only a subset of patients required intervention, typically due to sepsis, acute renal failure, or pain. No significant deterioration in median estimated glomerular filtration rate values was observed; however, patients with interventions showed higher anteroposterior diameter/parenchymal thickness ratios, suggesting increased parenchymal damage. Conclusions: Following radical cystectomy and Bricker ileal conduit diversion, mild to moderate hydronephrosis is not uncommon and does not always necessitate intervention, especially in patients without clinical symptoms. Radiological parameters like renal parenchymal thickness and kidney volume may be valuable for monitoring renal deterioration. Careful follow-up and selective intervention are crucial in preserving renal function in this patient group.
- 2 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5163
Open AccessUpper Urinary System Changes After Radical Cystectomy and Bricker Urinary Diversion: A Retrospective Evaluation of Functional and Radiological Parameters
Background/Objectives: Our objective is to evaluate the long-term effects of radical cystectomy and Bricker ileal conduit urinary diversion on upper urinary tract function and structure, with a specific focus on radiological and laboratory changes in renal function. Methods: A retrospective analysis was conducted of 120 patients who underwent radical cystectomy (RC) and Bricker ileal conduit urinary diversion between 2010 and 2024. Clinical, laboratory, and radiological data were assessed over a 24-month follow-up period. Renal parenchymal thickness, kidney volumes, and hydronephrosis grades were analyzed, and the relationship between interventions and renal outcomes was examined. Results: Postoperative follow-up showed a progressive decrease in renal parenchymal thickness and kidney volume, particularly in the left kidney. Hydronephrosis occurred in both renal units, with higher rates on the left side. Despite these changes, only a subset of patients required intervention, typically due to sepsis, acute renal failure, or pain. No significant deterioration in median estimated glomerular filtration rate values was observed; however, patients with interventions showed higher anteroposterior diameter/parenchymal thickness ratios, suggesting increased parenchymal damage. Conclusions: Following radical cystectomy and Bricker ileal conduit diversion, mild to moderate hydronephrosis is not uncommon and does not always necessitate intervention, especially in patients without clinical symptoms. Radiological parameters like renal parenchymal thickness and kidney volume may be valuable for monitoring renal deterioration. Careful follow-up and selective intervention are crucial in preserving renal function in this patient group.
- 10 June 2026
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 65 (2) , 313-320
Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma
Aim: To compare the diagnostic performance of the MRI-based clear cell likelihood score (ccLS), radiomics-based machine learning models, and their combination for differentiating clear cell renal cell carcinoma (ccRCC) from other renal tumor subtypes.Materials and Methods: This single-center retrospective study included patients with solid renal masses who underwent multiparametric MRI and had histopathologic confirmation. Lesions were evaluated using ccLS by two independent readers. Radiomic features were extracted from T1-weighted and T2-weighted images following standardized preprocessing. Multiple machine learning pipelines combining different feature selection methods and classifiers were evaluated using stratified 10-fold cross-validation with four repetitions. Using multivariable logistic regression, the radiomics score together with clinical factors and semantic imaging features were evaluated, and a nomogram was constructed based on the selected variables.Results: For differentiating ccRCC from other renal tumor subtypes, the ccLS model achieved an area under the receiver operating characteristic curve (AUC) of 0.832 (0.759–0.899). The best-performing radiomics-based machine learning model achieved a mean AUC of 0.89 ± 0.10. The combined model demonstrated higher diagnostic performance, with a mean AUC of 0.96 ± 0.01.Conclusions: Combining radiomics-based machine learning with established semantic MRI assessments was associated with improved differentiation of ccRCC from other renal tumor subtypes compared with individual approaches. Further validation in larger, multicenter cohorts is warranted before broader clinical application.
- 10 June 2026
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 65 (2) , 313-320
Integration of radiomics with MRI clear cell likelihood score for classification of clear cell renal cell carcinoma
Aim: To compare the diagnostic performance of the MRI-based clear cell likelihood score (ccLS), radiomics-based machine learning models, and their combination for differentiating clear cell renal cell carcinoma (ccRCC) from other renal tumor subtypes.Materials and Methods: This single-center retrospective study included patients with solid renal masses who underwent multiparametric MRI and had histopathologic confirmation. Lesions were evaluated using ccLS by two independent readers. Radiomic features were extracted from T1-weighted and T2-weighted images following standardized preprocessing. Multiple machine learning pipelines combining different feature selection methods and classifiers were evaluated using stratified 10-fold cross-validation with four repetitions. Using multivariable logistic regression, the radiomics score together with clinical factors and semantic imaging features were evaluated, and a nomogram was constructed based on the selected variables.Results: For differentiating ccRCC from other renal tumor subtypes, the ccLS model achieved an area under the receiver operating characteristic curve (AUC) of 0.832 (0.759–0.899). The best-performing radiomics-based machine learning model achieved a mean AUC of 0.89 ± 0.10. The combined model demonstrated higher diagnostic performance, with a mean AUC of 0.96 ± 0.01.Conclusions: Combining radiomics-based machine learning with established semantic MRI assessments was associated with improved differentiation of ccRCC from other renal tumor subtypes compared with individual approaches. Further validation in larger, multicenter cohorts is warranted before broader clinical application.
- 7 May 2026
- Published by Springer Nature in Virchows Archiv
- Vol. 489 (3) , 1-5
Renal cell carcinoma with a novel RAB1A::ALK fusion: expanding the molecular spectrum of ALK-rearranged RCC
Renal cell carcinoma associated with anaplastic lymphoma kinase rearrangement (ALK-RCC) is a rare subtype within the category of molecularly defined renal cell carcinomas. Due to its low incidence and highly heterogeneous clinicopathological features, ALK-RCC poses a significant diagnostic challenge. The implementation of advanced molecular techniques has facilitated the identification of various fusion partners, which may influence clinical behavior and guide targeted therapies. We report a case of ALK-RCC harboring a novel fusion partner, RAB1A::ALK. This report describes the clinicopathological and molecular features of the tumor, with a particular focus on the characterization of the RAB1A gene and its documented impact on carcinogenesis and prognosis across several solid malignancies. Our findings expand the molecular spectrum of ALK-RCC and emphasize the role of comprehensive molecular profiling in uropathology.
- 7 May 2026
- Published by Springer Nature in Virchows Archiv
- Vol. 489 (3) , 1-5
Renal cell carcinoma with a novel RAB1A::ALK fusion: expanding the molecular spectrum of ALK-rearranged RCC
Renal cell carcinoma associated with anaplastic lymphoma kinase rearrangement (ALK-RCC) is a rare subtype within the category of molecularly defined renal cell carcinomas. Due to its low incidence and highly heterogeneous clinicopathological features, ALK-RCC poses a significant diagnostic challenge. The implementation of advanced molecular techniques has facilitated the identification of various fusion partners, which may influence clinical behavior and guide targeted therapies. We report a case of ALK-RCC harboring a novel fusion partner, RAB1A::ALK. This report describes the clinicopathological and molecular features of the tumor, with a particular focus on the characterization of the RAB1A gene and its documented impact on carcinogenesis and prognosis across several solid malignancies. Our findings expand the molecular spectrum of ALK-RCC and emphasize the role of comprehensive molecular profiling in uropathology.
- Open Access
- 30 September 2025
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 29 (3) , 181-187
The Role of Urinary Secretory Immunoglobulin A in the Pathophysiology of Interstitial Cystitis
Purpose: This study aimed to determine whether urinary secretory immunoglobulin A (sIgA) levels differ between patients with bladder pain syndrome/interstitial cystitis (BPS/IC) and healthy controls, and to assess whether urinary sIgA is linked to mucosal immune mechanisms that may contribute to BPS/IC pathophysiology.Methods: A single-center, cross-sectional study was conducted between April and June 2020 at the Department of Urology, Ege University Faculty of Medicine. Forty female patients with BPS/IC and 40 healthy controls were enrolled. Symptom severity in the BPS/IC group was evaluated using the O’Leary-Sant Interstitial Cystitis Symptom and Problem Index. Patients with active urogenital infections, a history of bladder cancer, or prior pelvic radiotherapy were excluded. Urine samples were collected in sterile containers, centrifuged, and stored at -80°C before sIgA measurement using a commercial enzyme-linked immunosorbent assay kit. Correlations between continuous variables were examined with Spearman rank correlation coefficients.Results: Urinary sIgA levels were not significantly different between the BPS/IC group (mean±standard deviation: 0.96±1.5 μg/mL) and healthy controls (0.53±0.7 μg/mL) (P=0.173). Subgroup analyses within the BPS/IC cohort showed that smokers had significantly lower urinary sIgA levels (median [range], 0.001 [0.000–0.082] μg/mL) compared with nonsmokers (median [range], 0.720 [0.000–6.850] μg/mL) (P=0.004). Conversely, patients with cardiac comorbidities had significantly higher urinary sIgA levels (median [range], 0.820 [0.100–6.850] μg/mL) than those without cardiac disease (median [range], 0.213 [0.000–2.300] μg/mL) (P=0.015).Conclusions: Although no significant differences in urinary sIgA levels were observed between BPS/IC patients and healthy controls, subgroup analyses identified associations with smoking and cardiac comorbidities. These findings suggest that sIgA may be relevant to BPS/IC pathophysiology and highlight the potential of mucosal immune biomarkers. Larger studies are warranted to further clarify the role of sIgA in BPS/IC.
- 30 September 2025
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 29 (3) , 181-187
Open AccessThe Role of Urinary Secretory Immunoglobulin A in the Pathophysiology of Interstitial Cystitis
Purpose: This study aimed to determine whether urinary secretory immunoglobulin A (sIgA) levels differ between patients with bladder pain syndrome/interstitial cystitis (BPS/IC) and healthy controls, and to assess whether urinary sIgA is linked to mucosal immune mechanisms that may contribute to BPS/IC pathophysiology.Methods: A single-center, cross-sectional study was conducted between April and June 2020 at the Department of Urology, Ege University Faculty of Medicine. Forty female patients with BPS/IC and 40 healthy controls were enrolled. Symptom severity in the BPS/IC group was evaluated using the O’Leary-Sant Interstitial Cystitis Symptom and Problem Index. Patients with active urogenital infections, a history of bladder cancer, or prior pelvic radiotherapy were excluded. Urine samples were collected in sterile containers, centrifuged, and stored at -80°C before sIgA measurement using a commercial enzyme-linked immunosorbent assay kit. Correlations between continuous variables were examined with Spearman rank correlation coefficients.Results: Urinary sIgA levels were not significantly different between the BPS/IC group (mean±standard deviation: 0.96±1.5 μg/mL) and healthy controls (0.53±0.7 μg/mL) (P=0.173). Subgroup analyses within the BPS/IC cohort showed that smokers had significantly lower urinary sIgA levels (median [range], 0.001 [0.000–0.082] μg/mL) compared with nonsmokers (median [range], 0.720 [0.000–6.850] μg/mL) (P=0.004). Conversely, patients with cardiac comorbidities had significantly higher urinary sIgA levels (median [range], 0.820 [0.100–6.850] μg/mL) than those without cardiac disease (median [range], 0.213 [0.000–2.300] μg/mL) (P=0.015).Conclusions: Although no significant differences in urinary sIgA levels were observed between BPS/IC patients and healthy controls, subgroup analyses identified associations with smoking and cardiac comorbidities. These findings suggest that sIgA may be relevant to BPS/IC pathophysiology and highlight the potential of mucosal immune biomarkers. Larger studies are warranted to further clarify the role of sIgA in BPS/IC.
- Open Access
- 10 June 2025
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 64 (2) , 256-261
PSA dansitesinin robotik radikal prostatektomi sonuçlarına etkisinin incelenmesi
Amaç: Prostat spesifik antijen dansitesi (PSAD), prostat kanseri tanısında kullanılan serum prostat spesifik antijen (PSA) düzeyinin prostat volümüne oranlanması ile elde edilen tanısal bir belirteçtir. Prostat büyümesi ile PSA düzeylerindeki artışın korele olması nedeniyle tanısal değerlendirmede bu oran sıklıkla kullanılmaktadır ancak cerrahi sonuçların öngörülmesinde kullanılmamaktadır. Bu çalışmanın amacı, lokalize prostat kanseri için robotik radikal prostatektomi geçiren hastalarda PSA dansitesinin cerrahi sonuçlar ve postoperatif komplikasyonlar üzerindeki etkisini değerlendirmektir. Gereç ve Yöntem: Bu retrospektif kohort çalışması, Temmuz 2020 ile Haziran 2022 arasında robotik RP uygulanan 154 hastanın verilerini analiz etmiştir. PSAD, preoperatif PSA düzeyinin (ng/mL) transrektal ultrason (TRUS) veya multiparametrik MRG ile elde edilen prostat hacmine (mL) oranı olarak hesaplanmıştır. Elektronik dosya arşivi taraması ile toplanan veriler demografik bilgiler, preoperatif PSA düzeyleri, prostat hacmi, cerrahi parametreler ve postoperatif sonuçları içermektedir. Bulgular: Hastaların yaş ortalaması 65 (6,69) olup, yaş aralığı 46 ile 80 arasındadır. Preoperatif PSA düzeyleri 2.19 ile 35.4 ng/mL arasında değişmekte ve ortalama 7,75 (4,73) ng/mL olarak bulunmuştur. Prostat hacmi ortalama 47,73 (16,1) mL'dir. PSAD değerlerinin dağılımında hastaların %18,8'i düşük risk, %34,4'ü orta-düşük risk, %22,1'i orta-yüksek risk ve %24,7'si yüksek risk grubundadır. Daha yüksek PSAD ile pozitif cerrahi sınır oranları %18,75, %31,91, %44,12 ve %51,22 olarak saptanmıştır. PSAD'nin vezikoüretral anastomoz stenozu (VUAS) (p=0.8) veya anastomoz kaçakları (p=0.9) üzerinde anlamlı bir etkisi bulunmamıştır. Lojistik regresyon analizi, PSAD (katsayı 3.02, p=0.051) ve T3a kanserin (katsayı 1.48, p=0.018) pozitif cerrahi sınırların anlamlı prediktörleri olduğunu göstermiştir. ROC eğrisi analizinde, PSAD'nin AUC değerinin (0.65), T3a kanserin AUC değerinden (0.55) daha yüksek olduğu saptanmış olup bu durum PSAD’nin T3a kanserden daha iyi bir pozitif cerrahi sınır belirteci olabileceğini göstermektedir. Sonuç: Bu çalışma, robotik radikal prostatektomi geçiren hastalarda yüksek PSAD'nin pozitif cerrahi sınır riskini artırdığını ve cerrahi sonuçları öngörmede önemli bir biyobelirteç olabileceğini göstermektedir. Ancak, PSAD'nin postoperatif komplikasyonlar üzerinde anlamlı bir etkisi yoktur, bu da daha fazla araştırmaya ihtiyaç olduğunu göstermektedir. PSAD, cerrahi sonuçların iyileştirilmesinde önemli bir rol oynayabilir.
- 10 June 2025
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 64 (2) , 256-261
Open AccessPSA dansitesinin robotik radikal prostatektomi sonuçlarına etkisinin incelenmesi
Amaç: Prostat spesifik antijen dansitesi (PSAD), prostat kanseri tanısında kullanılan serum prostat spesifik antijen (PSA) düzeyinin prostat volümüne oranlanması ile elde edilen tanısal bir belirteçtir. Prostat büyümesi ile PSA düzeylerindeki artışın korele olması nedeniyle tanısal değerlendirmede bu oran sıklıkla kullanılmaktadır ancak cerrahi sonuçların öngörülmesinde kullanılmamaktadır. Bu çalışmanın amacı, lokalize prostat kanseri için robotik radikal prostatektomi geçiren hastalarda PSA dansitesinin cerrahi sonuçlar ve postoperatif komplikasyonlar üzerindeki etkisini değerlendirmektir. Gereç ve Yöntem: Bu retrospektif kohort çalışması, Temmuz 2020 ile Haziran 2022 arasında robotik RP uygulanan 154 hastanın verilerini analiz etmiştir. PSAD, preoperatif PSA düzeyinin (ng/mL) transrektal ultrason (TRUS) veya multiparametrik MRG ile elde edilen prostat hacmine (mL) oranı olarak hesaplanmıştır. Elektronik dosya arşivi taraması ile toplanan veriler demografik bilgiler, preoperatif PSA düzeyleri, prostat hacmi, cerrahi parametreler ve postoperatif sonuçları içermektedir. Bulgular: Hastaların yaş ortalaması 65 (6,69) olup, yaş aralığı 46 ile 80 arasındadır. Preoperatif PSA düzeyleri 2.19 ile 35.4 ng/mL arasında değişmekte ve ortalama 7,75 (4,73) ng/mL olarak bulunmuştur. Prostat hacmi ortalama 47,73 (16,1) mL'dir. PSAD değerlerinin dağılımında hastaların %18,8'i düşük risk, %34,4'ü orta-düşük risk, %22,1'i orta-yüksek risk ve %24,7'si yüksek risk grubundadır. Daha yüksek PSAD ile pozitif cerrahi sınır oranları %18,75, %31,91, %44,12 ve %51,22 olarak saptanmıştır. PSAD'nin vezikoüretral anastomoz stenozu (VUAS) (p=0.8) veya anastomoz kaçakları (p=0.9) üzerinde anlamlı bir etkisi bulunmamıştır. Lojistik regresyon analizi, PSAD (katsayı 3.02, p=0.051) ve T3a kanserin (katsayı 1.48, p=0.018) pozitif cerrahi sınırların anlamlı prediktörleri olduğunu göstermiştir. ROC eğrisi analizinde, PSAD'nin AUC değerinin (0.65), T3a kanserin AUC değerinden (0.55) daha yüksek olduğu saptanmış olup bu durum PSAD’nin T3a kanserden daha iyi bir pozitif cerrahi sınır belirteci olabileceğini göstermektedir. Sonuç: Bu çalışma, robotik radikal prostatektomi geçiren hastalarda yüksek PSAD'nin pozitif cerrahi sınır riskini artırdığını ve cerrahi sonuçları öngörmede önemli bir biyobelirteç olabileceğini göstermektedir. Ancak, PSAD'nin postoperatif komplikasyonlar üzerinde anlamlı bir etkisi yoktur, bu da daha fazla araştırmaya ihtiyaç olduğunu göstermektedir. PSAD, cerrahi sonuçların iyileştirilmesinde önemli bir rol oynayabilir.
- 30 October 2024
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 58 (4) , 366-379
Komplike Olmayan Üriner Sistem Enfeksiyonlarında Lokal Antibiyotik Direncinin Çok Merkezli Taranması: 37 Merkezden 1850 Hasta
Study demonstrated that antibiotic resistance in the treatment of uncomplicated urinary tract infections varies by geographical region. We believe this comprehensive, national prospective study will provide valuable insights for clinicians planning empirical treatment for uncomplicated urinary tract infections.
- 30 October 2024
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 58 (4) , 366-379
Komplike Olmayan Üriner Sistem Enfeksiyonlarında Lokal Antibiyotik Direncinin Çok Merkezli Taranması: 37 Merkezden 1850 Hasta
Study demonstrated that antibiotic resistance in the treatment of uncomplicated urinary tract infections varies by geographical region. We believe this comprehensive, national prospective study will provide valuable insights for clinicians planning empirical treatment for uncomplicated urinary tract infections.
- 1 September 2023
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 22 (3) , 100-105
Determination of the PSA Cut-off Value to Predict the Clinically Significant Prostate Cancer in Patients with Positive Multiparametric MRI: A Population-based Study
- 1 September 2023
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 22 (3) , 100-105
Determination of the PSA Cut-off Value to Predict the Clinically Significant Prostate Cancer in Patients with Positive Multiparametric MRI: A Population-based Study
- 11 July 2023
- Published by Wiley in International Journal of Urology
- Vol. 30 (11) , 985-990
Comparing the efficacy of extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy in the treatment of proximal ureteral stones in children: A retrospective study
Objectives: Ureteroscopic lithotripsy and extracorporeal shock wave lithotripsy methods are commonly used in the treatment of proximal ureteral stones. There are no adequate studies showing which method is more effective in children. In our study, we aimed to evaluate and compare the efficacy of two treatment methods, commonly used for proximal ureteral stones in children.Methods: A total of 78 patients who underwent ureteroscopic lithotripsy (n = 38) and extracorporeal shock wave lithotripsy (n = 40) due to stones located in the proximal ureter between 2010 and 2021 were included in the study. Demographic data, clinical characteristics, and treatment outcomes were retrospectively analyzed. Kolmogorov–Smirnov, Chi‐square, and Mann–Whitney U tests were used for statistical analysis.Results: There was no statistical difference between the demographic characteristics of the groups, except for the mean age values (p = 0.008). A statistically significant difference was found in favor of the extracorporeal shock wave lithotripsy group in terms of stone‐free rates after the first intervention, complication rates requiring intervention, re‐intervention rates, and the average number of anesthesia sessions per patient until stone‐free status (p = 0.043, p = 0.009, p = 0.017, and p < 0.001, respectively).Conclusions: The results of this retrospective study suggest that extracorporeal shock wave lithotripsy is the primary treatment option for single, non‐complicated proximal ureteral stones.
- 11 July 2023
- Published by Wiley in International Journal of Urology
- Vol. 30 (11) , 985-990
Comparing the efficacy of extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy in the treatment of proximal ureteral stones in children: A retrospective study
Objectives: Ureteroscopic lithotripsy and extracorporeal shock wave lithotripsy methods are commonly used in the treatment of proximal ureteral stones. There are no adequate studies showing which method is more effective in children. In our study, we aimed to evaluate and compare the efficacy of two treatment methods, commonly used for proximal ureteral stones in children.Methods: A total of 78 patients who underwent ureteroscopic lithotripsy (n = 38) and extracorporeal shock wave lithotripsy (n = 40) due to stones located in the proximal ureter between 2010 and 2021 were included in the study. Demographic data, clinical characteristics, and treatment outcomes were retrospectively analyzed. Kolmogorov–Smirnov, Chi‐square, and Mann–Whitney U tests were used for statistical analysis.Results: There was no statistical difference between the demographic characteristics of the groups, except for the mean age values (p = 0.008). A statistically significant difference was found in favor of the extracorporeal shock wave lithotripsy group in terms of stone‐free rates after the first intervention, complication rates requiring intervention, re‐intervention rates, and the average number of anesthesia sessions per patient until stone‐free status (p = 0.043, p = 0.009, p = 0.017, and p < 0.001, respectively).Conclusions: The results of this retrospective study suggest that extracorporeal shock wave lithotripsy is the primary treatment option for single, non‐complicated proximal ureteral stones.
- Open Access
- 12 December 2022
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 61 (4) , 577-585
Investigation of ERG and PTEN expressions in benign, precursor and malignant epithelial proliferations of prostate and clinicopathological correlation of findings
Amaç: Prostat kanseri farklı klinik gidişata ve geniş bir tedavi yelpazesine sahip, klinik ve moleküler olarak oldukça heterojen bir kanser türüdür. Özellikle “prostatik intraepitelyal neoplazi” (PİN), “atipik intraduktal proliferasyon” (AİP) ve “intraduktal karsinom” (İDK) benzer morfolojik özelliklere sahip olması açısından ayırıcı tanı zorluğu yaratan tanılar olup, hasta tedavi ve takibi de farklı olan antitelerdir. Çalışmamızda bu lezyonlarda ERG ve PTEN ekspresyon düzeylerini belirlemeyi ve bu biyobelirteçlerin prognostik ve diagnostik değerini araştırmayı amaçladık. Gereç ve Yöntem: EÜTF Tıbbi Patoloji Anabilim Dalında 2011-2012 yılında radikal prostatektomi veya iğne biyopsi materyallerinde “Adenokarsinom” tanısı almış 87 olgu çalışmaya alındı. Histopatolojik olarak AİP, İDK ve PİN içeren alanlar belirlendi. immunohistokimyasal olarak bu alanlarda ERG ve PTEN ekspresyonları değerlendirildi. Bulgular: Olguların 6’sında İDK, 29’unda AİP ve 52’sinde PİN belirlendi. İDK AİP, DG 3 ve üstünde olan tümörlerde daha fazla görüldü. İDK ve AİP in eşlik ettiği prostat karsinomlarının sağ kalım süresi daha kısaydı (p=0.043). İDK ve AİP içeren tümörlerde ERG ve PTEN durumu invaziv komponentle uyum içindeydi. Ayrıca tüm İDK alanlarında ERG pozitifti. PTEN ile heterojen boyanma görülmüş olup, PTEN’in invaziv karsinom ve İDK alanlarında negatifliği daha fazlaydı (p=0,63). ERG pozitifliği ve PTEN negatifliği istatistiksel olarak anlamlı olmamakla birlikte AİP tanısını desteklediği dikkati çekti. Sonuç: Özellikle ayırıcı tanı sorunu yaratan intraduktal lezyonlarda ERG pozitifliği ve PTEN negatifliği klinik öneme sahip prostat karsinomuna eşlik edebileceği için özellikle biyopsilerde gözardı edilmemeli ve hasta tedavi ile takibi buna göre yapılmalıdır.
- 12 December 2022
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 61 (4) , 577-585
Open AccessInvestigation of ERG and PTEN expressions in benign, precursor and malignant epithelial proliferations of prostate and clinicopathological correlation of findings
Amaç: Prostat kanseri farklı klinik gidişata ve geniş bir tedavi yelpazesine sahip, klinik ve moleküler olarak oldukça heterojen bir kanser türüdür. Özellikle “prostatik intraepitelyal neoplazi” (PİN), “atipik intraduktal proliferasyon” (AİP) ve “intraduktal karsinom” (İDK) benzer morfolojik özelliklere sahip olması açısından ayırıcı tanı zorluğu yaratan tanılar olup, hasta tedavi ve takibi de farklı olan antitelerdir. Çalışmamızda bu lezyonlarda ERG ve PTEN ekspresyon düzeylerini belirlemeyi ve bu biyobelirteçlerin prognostik ve diagnostik değerini araştırmayı amaçladık. Gereç ve Yöntem: EÜTF Tıbbi Patoloji Anabilim Dalında 2011-2012 yılında radikal prostatektomi veya iğne biyopsi materyallerinde “Adenokarsinom” tanısı almış 87 olgu çalışmaya alındı. Histopatolojik olarak AİP, İDK ve PİN içeren alanlar belirlendi. immunohistokimyasal olarak bu alanlarda ERG ve PTEN ekspresyonları değerlendirildi. Bulgular: Olguların 6’sında İDK, 29’unda AİP ve 52’sinde PİN belirlendi. İDK AİP, DG 3 ve üstünde olan tümörlerde daha fazla görüldü. İDK ve AİP in eşlik ettiği prostat karsinomlarının sağ kalım süresi daha kısaydı (p=0.043). İDK ve AİP içeren tümörlerde ERG ve PTEN durumu invaziv komponentle uyum içindeydi. Ayrıca tüm İDK alanlarında ERG pozitifti. PTEN ile heterojen boyanma görülmüş olup, PTEN’in invaziv karsinom ve İDK alanlarında negatifliği daha fazlaydı (p=0,63). ERG pozitifliği ve PTEN negatifliği istatistiksel olarak anlamlı olmamakla birlikte AİP tanısını desteklediği dikkati çekti. Sonuç: Özellikle ayırıcı tanı sorunu yaratan intraduktal lezyonlarda ERG pozitifliği ve PTEN negatifliği klinik öneme sahip prostat karsinomuna eşlik edebileceği için özellikle biyopsilerde gözardı edilmemeli ve hasta tedavi ile takibi buna göre yapılmalıdır.
- 11 December 2022
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 62 (3) , 332-338
Üst üriner sistem ürotelyal karsinomlarinda tümör boyutu ve yerleşimi sağ kalımı etkiler mi?
Aim: This study aimed to evaluate the effect of tumor location based on clinicopathologic features on cancer-specific survival (CSS) of patients who were treated surgically for locally/locally advanced upper tract urothelial carcinoma (UTUC). Materials and Methods: A single-center series of 145 patients with UTUC who underwent radical nephroureterectomy between May 2010 and August 2019 were included in the study. Patients were stratified based on the location of the tumor as renal pelvis and ureter located tumor. Clinicopathologic characteristics and oncological outcomes were compared according to tumor location and CSS rates after surgery were graphically explored using Kaplan–Meier curves. Results: At a mean follow-up time of 41.8 (4-124) months after surgery, 65 patients (44.8%) died from UTUC. Kaplan-Meier curves showed that tumor location was not associated with CSS in the analysis performed according to tumor stage, grade, and size. In the analysis that was conducted without regard to tumor location, worse CSS was found for patients with pT3 disease versus those with ≤pT2 and with high-grade tumors versus those with low-grade (p=0.025 and p=0.011, respectively). Conclusion: Tumor location was not associated with CSS in any of the analyses. Regardless of tumor location, patients with pT3 disease and high-grade tumors, have a worse prognosis. Further studies on prognostic factors are needed to evaluate the advantages of these factors in the management of patients with UTUC.
- 11 December 2022
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 62 (3) , 332-338
Üst üriner sistem ürotelyal karsinomlarinda tümör boyutu ve yerleşimi sağ kalımı etkiler mi?
Aim: This study aimed to evaluate the effect of tumor location based on clinicopathologic features on cancer-specific survival (CSS) of patients who were treated surgically for locally/locally advanced upper tract urothelial carcinoma (UTUC). Materials and Methods: A single-center series of 145 patients with UTUC who underwent radical nephroureterectomy between May 2010 and August 2019 were included in the study. Patients were stratified based on the location of the tumor as renal pelvis and ureter located tumor. Clinicopathologic characteristics and oncological outcomes were compared according to tumor location and CSS rates after surgery were graphically explored using Kaplan–Meier curves. Results: At a mean follow-up time of 41.8 (4-124) months after surgery, 65 patients (44.8%) died from UTUC. Kaplan-Meier curves showed that tumor location was not associated with CSS in the analysis performed according to tumor stage, grade, and size. In the analysis that was conducted without regard to tumor location, worse CSS was found for patients with pT3 disease versus those with ≤pT2 and with high-grade tumors versus those with low-grade (p=0.025 and p=0.011, respectively). Conclusion: Tumor location was not associated with CSS in any of the analyses. Regardless of tumor location, patients with pT3 disease and high-grade tumors, have a worse prognosis. Further studies on prognostic factors are needed to evaluate the advantages of these factors in the management of patients with UTUC.